Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA duplex, or double-stranded deoxyribonucleic acid, is the fundamental molecule of heredity, consisting of two polynucleotide chains coiled around each other to form a double helix (National Human Genome Research Institute, 2023). It functions as the primary storage site for genetic instructions necessary for the development, survival, and reproduction of all known living organisms and many viruses. In the context of therapeutics, the DNA duplex is a major target for cytotoxic chemotherapy, where agents disrupt the integrity of the helix to halt the proliferation of malignant cells (StatPearls, 2023). Drugs interact with the DNA duplex through various mechanisms, including intercalation between base pairs, covalent bonding to form adducts, or binding within the major and minor grooves (PubChem, 2024). While highly effective in treating various cancers and certain infections, targeting the DNA duplex carries significant risks of genotoxicity and secondary cancers due to its presence in healthy cells (National Cancer Institute, 2022). Additionally, the presence of antibodies against the DNA duplex is a hallmark biomarker for autoimmune conditions such as systemic lupus erythematosus (Mayo Clinic, 2023).
Drugs targeting the DNA duplex typically act through covalent cross-linking (alkylation), non-covalent insertion between base pairs (intercalation), or induction of strand breaks via oxidative stress, ultimately leading to the inhibition of replication and transcription and the induction of apoptosis (StatPearls, 2023; PubChem, 2024).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic acid duplex (DNA duplex) (DNA).